Table 5.
Immune-related adverse events (n = 34)
| Event | All grades, n (%) | Grade 1–2, n (%) | Grade 3, n (%) |
|---|---|---|---|
| Hypothyroidism | 9 (26.5) | 9 (26.5) | 0 (0) |
| Thyroid-stimulating hormone increased | 6 (17.6) | 6 (17.6) | 0 (0) |
| Hyperthyroidism | 3 (8.8) | 3 (8.8) | 0 (0) |
| Alanine aminotransferase increased | 2 (5.9) | 2 (5.9) | 0 (0) |
| Aspartate aminotransferase increased | 2 (5.9) | 2 (5.9) | 0 (0) |
| Arthritis | 1 (2.9) | 1 (2.9) | 0 (0) |
| Diarrhea | 1 (2.9) | 1 (2.9) | 0 (0) |
| Mucositis oral | 1 (2.9) | 1 (2.9) | 0 (0) |
| Immune-related pneumonitis | 1 (2.9) | 1 (2.9) | 0 (0) |
| Rash | 1 (2.9) | 1 (2.9) | 0 (0) |
| Skin reaction | 1 (2.9) | 1 (2.9) | 0 (0) |
| Blood bilirubin increased | 1 (2.9) | 1 (2.9) | 0 (0) |
AEs were summarized with descriptive statistics.